Evidence map›Paper›PMID 32045511›Full record

ReviewWiley interdisciplinary reviews. RNA2020

Retroelement origins of pre-mRNA splicing.

Daniel B Haack, Navtej Toor

Open access · greenAbstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. RNA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Decoding branch points and unlocking splicing secrets.Nature structural & molecular biology · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Daniel B HaackDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California.ORCID 0000-0002-4926-7772
Navtej ToorDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California.ORCID 0000-0002-6134-163X
University of California San Diego · US

Funding

Structural Biology of Retrotransposition (Equipment Supplement)R01GM123275 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TOOR, NAVTEJ SINGH · 2017 to 2020
$1.3M
NIGMS NIH HHS GM123275NIGMS NIH HHS R01 GM123275
6 · The paper itself

Abstract

Recent cryo-EM structures of a group II intron caught in the process of invading DNA have given new insight into the mechanisms of both splicing and retrotransposition. Conformational dynamics involving the branch-site helix domain VI are responsible for substrate exchange between the two steps of splicing. These structural rearrangements have strong parallels with the movement of the branch-site helix in the spliceosome during catalysis. This is strong evidence for the spliceosome evolving from a group II intron ancestor. We observe other topological changes in the overall structure of the catalytic domain V that may occur in the spliceosome as well. Therefore, studying group II introns not only provides us with insight into the evolutionary origins of the spliceosome, but also may inform the design of experiments to further probe structure-function relationships in this eukaryotic splicing apparatus. This article is categorized under: RNA Processing > Splicing Mechanisms RNA Structure and Dynamics > RNA Structure, Dynamics, and Chemistry RNA Structure and Dynamics > Influence of RNA Structure in Biological Systems RNA Evolution and Genomics > RNA and Ribonucleoprotein Evolution.

Indexed as

IntronsNucleic Acid ConformationRetroelementsRNA PrecursorsRNA SplicingRetroelementsRNA Precursorsgroup II intronRNA splicingspliceosome

Identifiers

PMID32045511
PMCPMC7340585
OpenAlexW3006450920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.